MedPath

Reprexain

REPREXAIN (hydrocodone bitartrate, ibuprofen) tablet, film coated

Approved
Approval ID

fe580e12-03fa-4678-9887-458297007441

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 27, 2009

Manufacturers
FDA

Stat Rx USA

DUNS: 786036330

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydrocodone Bitartrate, Ibuprofen

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-878
Application NumberANDA076642
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydrocodone Bitartrate, Ibuprofen
Product Specifications
Route of AdministrationORAL
Effective DateOctober 27, 2009
FDA Product Classification

INGREDIENTS (2)

Hydrocodone BitartrateActive
Quantity: 5 mg in 1 1
Code: NO70W886KK
Classification: ACTIB
IbuprofenActive
Quantity: 200 mg in 1 1
Code: WK2XYI10QM
Classification: ACTIB

Hydrocodone Bitartrate, Ibuprofen

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-276
Application NumberANDA076642
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydrocodone Bitartrate, Ibuprofen
Product Specifications
Route of AdministrationORAL
Effective DateOctober 27, 2009
FDA Product Classification

INGREDIENTS (2)

Hydrocodone BitartrateActive
Quantity: 10 mg in 1 1
Code: NO70W886KK
Classification: ACTIB
IbuprofenActive
Quantity: 200 mg in 1 1
Code: WK2XYI10QM
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Reprexain - FDA Drug Approval Details